DermTech Inc (DermTech) is a genomics company that develops and markets novel non-invasive genomic tests to aid in diagnosing and managing melanoma. The company provides DermTech Melanoma Test (DMT), an innovative non-invasive way to enhance melanoma detection for developing product for non-melanoma skin cancers. It also offers DermTech Smart Sticker, which provides a non-invasively way to collect skin sample including standard care by using scalpel to biopsy suspicious lesions. DermTech develops gene expression assays for the psoriasis, atopic dermatitis and aging of the skin to pharmaceutical companies to develop drug products in dermatology. DermTech is headquartered in San Diego, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company DermTech Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- DermTech Inc Company Overview
- DermTech Inc Company Snapshot
- DermTech Inc Pipeline Products and Ongoing Clinical Trials Overview
- DermTech Inc - Pipeline Analysis Overview
- DermTech Inc - Key Facts
- DermTech Inc - Major Products and Services
- DermTech Inc Pipeline Products by Development Stage
- DermTech Inc Pipeline Products Overview
- Carcinome
- Carcinome Product Overview
- Diagnostic Assay - CTCL
- Diagnostic Assay - CTCL Product Overview
- Luminate SM
- Luminate SM Product Overview
- qPCR Assay - Psoriasis
- qPCR Assay - Psoriasis Product Overview
- qPCR Assay - Skin Aging
- qPCR Assay - Skin Aging Product Overview
- ResponseAD
- ResponseAD Product Overview
- DermTech Inc - Key Competitors
- DermTech Inc - Key Employees
- DermTech Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- DermTech Inc, Recent Developments
- Jan 18, 2024: DermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin Types
- Jan 16, 2024: DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay
- Jan 08, 2024: DermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT)
- Oct 12, 2023: DermTech Announces Release Date for Third-Quarter 2023 Financial Results
- Sep 11, 2023: DermTech Appoints Mark Aguillard as Chief Commercial Officer
- Aug 03, 2023: DermTech Reports Second-Quarter 2023 Financial Results
- Jul 19, 2023: DermTech Announces Favorable Coverage Policy With Blues Plan in Michigan for the Foundational Assay of Its DermTech Melanoma Test (DMT)
- Jul 12, 2023: DermTech Adds Approximately 7 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT)
- Jun 14, 2023: ECRI Completes Evaluation of the Pigmented Lesion Assay (PLA), the Foundational Assay for the DermTech Melanoma Test (DMT)
- Jun 07, 2023: DermTech announces contract with Hawaii Blues Plan for the foundational assay of its DermTech melanoma test (DMT)
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- DermTech Inc Pipeline Products and Ongoing Clinical Trials Overview
- DermTech Inc Pipeline Products by Equipment Type
- DermTech Inc Pipeline Products by Indication
- DermTech Inc, Key Facts
- DermTech Inc, Major Products and Services
- DermTech Inc Number of Pipeline Products by Development Stage
- DermTech Inc Pipeline Products Summary by Development Stage
- Carcinome - Product Status
- Carcinome - Product Description
- Diagnostic Assay - CTCL - Product Status
- Diagnostic Assay - CTCL - Product Description
- Luminate SM - Product Status
- Luminate SM - Product Description
- qPCR Assay - Psoriasis - Product Status
- qPCR Assay - Psoriasis - Product Description
- qPCR Assay - Skin Aging - Product Status
- qPCR Assay - Skin Aging - Product Description
- ResponseAD - Product Status
- ResponseAD - Product Description
- DermTech Inc, Key Employees
- DermTech Inc, Subsidiaries
- Glossary
- DermTech Inc Pipeline Products by Equipment Type
- DermTech Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Verisante Technology Inc
- Castle Biosciences Inc
- Canfield Scientific Inc
- Spear Pharmaceuticals Inc
- MedX Health Corp
- Caliber Imaging & Diagnostics Inc
- MELA Sciences, Inc.
- Leo Pharma AS
- Mindera Corp
